Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

NKL homeobox gene activities in hematopoietic stem cells, T-cell development and T-cell leukemia.

Nagel S, Pommerenke C, Scherr M, Meyer C, Kaufmann M, Battmer K, MacLeod RA, Drexler HG.

PLoS One. 2017 Feb 2;12(2):e0171164. doi: 10.1371/journal.pone.0171164. eCollection 2017.

2.

High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.

Gerby B, Veiga DF, Krosl J, Nourreddine S, Ouellette J, Haman A, Lavoie G, Fares I, Tremblay M, Litalien V, Ottoni E, Kosic M, Geoffrion D, Ryan J, Maddox PS, Chagraoui J, Marinier A, Hébert J, Sauvageau G, Kwok BH, Roux PP, Hoang T.

J Clin Invest. 2016 Dec 1;126(12):4569-4584. doi: 10.1172/JCI86489. Epub 2016 Oct 31.

3.

MiR-146b negatively regulates migration and delays progression of T-cell acute lymphoblastic leukemia.

Correia NC, Fragoso R, Carvalho T, Enguita FJ, Barata JT.

Sci Rep. 2016 Aug 23;6:31894. doi: 10.1038/srep31894.

4.

Intracellular Signaling Pathways Involved in Childhood Acute Lymphoblastic Leukemia; Molecular Targets.

Layton Tovar CF, Mendieta Zerón H.

Indian J Hematol Blood Transfus. 2016 Jun;32(2):141-53. doi: 10.1007/s12288-015-0609-z. Epub 2015 Oct 20. Review.

5.

UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.

Benyoucef A, Palii CG, Wang C, Porter CJ, Chu A, Dai F, Tremblay V, Rakopoulos P, Singh K, Huang S, Pflumio F, Hébert J, Couture JF, Perkins TJ, Ge K, Dilworth FJ, Brand M.

Genes Dev. 2016 Mar 1;30(5):508-21. doi: 10.1101/gad.276790.115.

6.

TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation.

Ferri F, Parcelier A, Petit V, Gallouet AS, Lewandowski D, Dalloz M, van den Heuvel A, Kolovos P, Soler E, Squadrito ML, De Palma M, Davidson I, Rousselet G, Romeo PH.

Nat Commun. 2015 Nov 23;6:8900. doi: 10.1038/ncomms9900.

7.

SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.

Gerby B, Tremblay CS, Tremblay M, Rojas-Sutterlin S, Herblot S, Hébert J, Sauvageau G, Lemieux S, Lécuyer E, Veiga DF, Hoang T.

PLoS Genet. 2014 Dec 18;10(12):e1004768. doi: 10.1371/journal.pgen.1004768. eCollection 2014 Dec.

8.

Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression.

Uzan B, Poglio S, Gerby B, Wu CL, Gross J, Armstrong F, Calvo J, Cahu X, Deswarte C, Dumont F, Passaro D, Besnard-Guérin C, Leblanc T, Baruchel A, Landman-Parker J, Ballerini P, Baud V, Ghysdael J, Baleydier F, Porteu F, Pflumio F.

EMBO Mol Med. 2014 Jun;6(6):821-34. doi: 10.1002/emmm.201303286. Epub 2014 Apr 6.

9.

Loss of GATA3 in bladder cancer promotes cell migration and invasion.

Li Y, Ishiguro H, Kawahara T, Kashiwagi E, Izumi K, Miyamoto H.

Cancer Biol Ther. 2014 Apr;15(4):428-35. doi: 10.4161/cbt.27631. Epub 2014 Jan 21.

10.

MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia.

Astolfi A, Vendemini F, Urbini M, Melchionda F, Masetti R, Franzoni M, Libri V, Serravalle S, Togni M, Paone G, Montemurro L, Bressanin D, Chiarini F, Martelli AM, Tonelli R, Pession A.

Oncotarget. 2014 Jan 15;5(1):120-30.

11.

Structural analysis of microRNA-target interaction by sequential seed mutagenesis and stem-loop 3' RACE.

Bohmer M, Sharbati J, Zur Bruegge J, Einspanier R, Sharbati S.

PLoS One. 2013 Nov 25;8(11):e81427. doi: 10.1371/journal.pone.0081427. eCollection 2013.

13.

The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.

Mansour MR, Sanda T, Lawton LN, Li X, Kreslavsky T, Novina CD, Brand M, Gutierrez A, Kelliher MA, Jamieson CH, von Boehmer H, Young RA, Look AT.

J Exp Med. 2013 Jul 29;210(8):1545-57. doi: 10.1084/jem.20122516. Epub 2013 Jul 15.

14.

Ectopic expression of homeobox gene NKX2-1 in diffuse large B-cell lymphoma is mediated by aberrant chromatin modifications.

Nagel S, Ehrentraut S, Tomasch J, Quentmeier H, Meyer C, Kaufmann M, Drexler HG, MacLeod RA.

PLoS One. 2013 Apr 29;8(4):e61447. doi: 10.1371/journal.pone.0061447. Print 2013. Erratum in: PLoS One. 2013;8(6). doi:10.1371/annotation/3989404d-132f-4f07-a39e-c060d9094611.

15.

An integrative computational systems biology approach identifies differentially regulated dynamic transcriptome signatures which drive the initiation of human T helper cell differentiation.

Aijö T, Edelman SM, Lönnberg T, Larjo A, Kallionpää H, Tuomela S, Engström E, Lahesmaa R, Lähdesmäki H.

BMC Genomics. 2012 Oct 30;13:572. doi: 10.1186/1471-2164-13-572.

16.

Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.

Sanda T, Lawton LN, Barrasa MI, Fan ZP, Kohlhammer H, Gutierrez A, Ma W, Tatarek J, Ahn Y, Kelliher MA, Jamieson CH, Staudt LM, Young RA, Look AT.

Cancer Cell. 2012 Aug 14;22(2):209-21. doi: 10.1016/j.ccr.2012.06.007.

17.

Transcriptional activation of prostate specific homeobox gene NKX3-1 in subsets of T-cell lymphoblastic leukemia (T-ALL).

Nagel S, Ehrentraut S, Tomasch J, Lienenklaus S, Schneider B, Geffers R, Meyer C, Kaufmann M, Drexler HG, MacLeod RA.

PLoS One. 2012;7(7):e40747. doi: 10.1371/journal.pone.0040747. Epub 2012 Jul 27.

18.

Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis.

Anderson PD, McKissic SA, Logan M, Roh M, Franco OE, Wang J, Doubinskaia I, van der Meer R, Hayward SW, Eischen CM, Eltoum IE, Abdulkadir SA.

J Clin Invest. 2012 May;122(5):1907-19. doi: 10.1172/JCI58540. Epub 2012 Apr 9.

19.

Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.

Li Y, Deng C, Hu X, Patel B, Fu X, Qiu Y, Brand M, Zhao K, Huang S.

Oncogene. 2012 Nov 29;31(48):5007-18. doi: 10.1038/onc.2012.8. Epub 2012 Feb 6.

20.

GATA Transcription Factors and Cancer.

Zheng R, Blobel GA.

Genes Cancer. 2010 Dec;1(12):1178-88. doi: 10.1177/1947601911404223.

Supplemental Content

Support Center